MedDataX Logo

Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment

NCT ID: NCT01083147

Last Updated: 2010-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-10-31

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a non-randomized cohort, multi-center study. The eligible subjects will be asked to use the FORESEE HOME device daily and the tests results will be automatically transmitted to the Data Monitor Center for analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Age-Related Macular Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dry AMD

subjects diagnosed as intermediate AMD in at least one eye

FORESEE HOME

Intervention Type DEVICE

Home Monitoring

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FORESEE HOME

Home Monitoring

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who successfully completed participation in ForeseeHome-US2 study
* Patients with ability to comprehend and sign the informed consent/authorization

Exclusion Criteria

* Subjects who failed to complete participation in ForeseeHome-US2 study
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Notal Vision Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Notal Vision

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniel Roth, MD

Role: PRINCIPAL_INVESTIGATOR

Vitreos retina center - NJ

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vitreos retina center

Toms River, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ForeseeHome-US3

Identifier Type: -

Identifier Source: org_study_id